BEIJING BIOSTAR PHARMACEUTICALS CO revenue breakdown overview

BEIJING BIOSTAR PHARMACEUTICALS CO revenue for the last year amounted to 91.53 M HKD, the most of which — 73.63 M HKD — came from its highest performing source at the moment, Anti-cancer Drugs, the year earlier bringing 38.17 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING BIOSTAR PHARMACEUTICALS CO 73.63 M HKD, and the year before that — 38.17 M HKD.